Evidence map›Paper›PMID 35773719›Full record

ArticleIMA fungus2022

Species determination using AI machine-learning algorithms: Hebeloma as a case study.

Peter Bartlett, Ursula Eberhardt, Nicole Schütz, Henry J Beker

Abstract read
In one paragraph

Article in IMA fungus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Classification of Mycena andSensors (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter BartlettLa Baraka, Gorse Hill Road, Virginia Water, Surrey, GU25 4AP, UK.ORCID https://orcid.org/0000-0002-8800-3219
Ursula EberhardtStaatliches Museum für Naturkunde Stuttgart, Rosenstein 1, 70191, Stuttgart, Germany. ursula.eberhardt@smns-bw.de.ORCID http://orcid.org/0000-0003-1221-7074
Nicole SchützStaatliches Museum für Naturkunde Stuttgart, Rosenstein 1, 70191, Stuttgart, Germany.
Henry J Beker, Rue Père de Deken 19, 1040, Bruxelles, Belgium.ORCID https://orcid.org/0000-0001-9620-1701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genus Hebeloma is renowned as difficult when it comes to species determination. Historically, many dichotomous keys have been published and used with varying success rate. Over the last 20 years the authors have built a database of Hebeloma collections containing not only metadata but also parametrized morphological descriptions, where for about a third of the cases micromorphological characters have been analysed and are included, as well as DNA sequences for almost every collection. The database now has about 9000 collections including nearly every type collection worldwide and represents over 120 different taxa. Almost every collection has been analysed and identified to species using a combination of the available molecular and morphological data in addition to locality and habitat information. Based on these data an Artificial Intelligence (AI) machine-learning species identifier has been developed that takes as input locality data and a small number of the morphological parameters. Using a random test set of more than 600 collections from the database, not utilized within the set of collections used to train the identifier, the species identifier was able to identify 77% correctly with its highest probabilistic match, 96% within its three most likely determinations and over 99% of collections within its five most likely determinations.

Indexed as

AgaricalesEctomycorrhizal fungiIdentification keysNeural networksTaxonomy

Identifiers

PMID35773719
PMCPMC9245212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.